Rensair, a London, UK-based air purification company, raised $7m in Series A financing.
The round was led by Hoxton Ventures.
The company intends to use the funds to expand its presence across the world, introduce a broader product portfolio with IoT connectivity, and invest in marketing outreach.
Founded in May 2020 by Danish twins Christian and Frederik Hendriksen, Rensair provides a portable hospital-grade air purifier to Scandinavian hospitals, and is now extending applications across all industries, from care homes, dental practices and offices, to gyms, entertainment venues and retail outlets. The device traps and destroys airborne bacteria and viruses, including the Coronavirus family.
The company currently serves over 800 customers including CBRE, Disney, Morgan Stanley, PepsiCo, SNCF, and the UK National Health Service (NHS).
Rensair, whose first year’s sales were in the millions, is also announcing that it has acquired the air filtration business of AirLabs, a UK and Denmark-based air cleaning and monitoring company. The acquisition brings complementary filtration and IoT technologies, as well as established products such as the compact AirBubbl that supplies purified air to personal spaces and can be fitted to car seat headrests or mounted in driver cabins.
Rensair is headquartered in London with operations in the UK, Europe, USA and Asia.